A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways.
Details
Publication Year 2013-08-28, Volume 11, Issue #1, Page 188
Journal Title
BMC Medicine
Publication Type
JOURNAL ARTICLE
Abstract
Changing perspectives on the natural history of celiac disease (CD), new serology and genetic tests, and amended histological criteria for diagnosis cast doubt on past prevalence estimates for CD. We set out to establish a more accurate prevalence estimate for CD using a novel serogenetic approach.
Publisher
BioMed Central
Keywords
Celiac disease; Diagnosis; Epidemiology; Serology; Transglutaminase; Deamidated gliadin peptide; Immunogenetics; Prevalence
WEHI Research Division(s)
Immunology
Rights Notice
© 2013 Anderson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Creation Date: 2013-08-28 12:00:00
Last Modified: 0001-01-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙